Gufic Biosciences Gets Two Patent Certificates Stock Soars Over 5%

Gufic Biosciences on Monday informed the bourses that it has received two patent certificates from the Intellectual Property India, The Patent Office.

It has been granted patents for two formulations viz. process for the preparation of the parental formulation of Anidulafungin, and a freeze dried parental composition of Tigecycline and process for the preparation of it.

Meanwhile, Gufic Biosciences was up by 5.6% at Rs 72.45 per share at 11:23 hours IST on BSE. It hit a high of Rs 73.75 and a low of Rs 71.25 during the early market hours.

The stock has delivered stellar returns of more than 70% over one year’s time. It has also outperformed BSE small-cap and BSE Healthcare over the same period.

Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products. The company's segments include pharma, including formulations and bulk drugs.

For Quick Trial – 8962000225 ✔ 
or mail us here:
or visit
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔
Share on Google Plus Share on Pinterest

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.